A Bioinspired Lipopeptide Surmounts Therapeutic Dilemmas of Gram-Positive and Gram-Negative Polymicrobial Infection

Area of Science:

• Microbiology
• Medicinal Chemistry
• Infectious Diseases

Background:

• Polymicrobial infections involving Gram-positive and Gram-negative bacteria pose significant therapeutic challenges.
• Current antimicrobial agents often lack efficacy against such complex infections.
• Targeting distinct bacterial membrane structures offers a potential strategy for broad-spectrum antimicrobial development.

Purpose of the Study:

• To design and develop novel antimicrobials targeting both Gram-positive and Gram-negative bacterial membranes.
• To identify a promising lipid scaffold for membrane disruption.
• To evaluate the efficacy and safety of the developed lipopeptide, LP3K, against polymicrobial infections.

Main Methods:

• Lipid screening to identify membrane-disrupting scaffolds.
• Chemical optimization to design an inverted-conical lipopeptide (LP3K).
• Structure-activity relationship and mechanism of action elucidation.
• In vivo testing in a mouse model of polymicrobial infection.

Main Results:

• A novel lipopeptide, LP3K, was developed with broad-spectrum antimicrobial activity.
• LP3K demonstrated efficacy against polymicrobial infections by disrupting bacterial membrane systems.
• No emergence of resistance was observed with LP3K treatment.
• Significant antimicrobial and therapeutic effects were confirmed in a preclinical mouse model with demonstrated in vivo biosafety.

Conclusions:

• Lipopeptides represent a promising class of clinically translatable antimicrobials.
• LP3K shows potential for the effective treatment of challenging polymicrobial infections.
• Targeting bacterial membranes provides a viable strategy for developing new anti-infective agents.